MARKET

OPHLF

OPHLF

Ono Pharmaceutic
OTCPK
12.22
NaN%
Closed 09:30 02/06 EST
OPEN
--
PREV CLOSE
12.22
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
12.22
52 WEEK LOW
10.17
MARKET CAP
5.74B
P/E (TTM)
17.42
1D
5D
1M
3M
1Y
5Y
1D
Ono Pharmaceutical GAAP EPS of ¥146.07, revenue of ¥397.04B; reaffirms FY outlook
Seeking Alpha · 6d ago
Ono Pharmaceutical Co. Ltd. Reveals Climb In Nine Months Bottom Line
NASDAQ · 6d ago
ONO Pharmaceutical Posts Strong Profit Growth in Q3 FY2025 and Maintains Full-Year Outlook
TipRanks · 6d ago
Ono Pharma Taiwan Receives Additional Approval Of Opdivo In Combination With Ipilimumab
NASDAQ · 01/14 07:12
Ono Pharmaceutical reports Q2 results
Seeking Alpha · 10/30/2025 12:52
ONO Pharmaceutical Reports Strong Q2 Financial Performance with Revenue Growth
TipRanks · 10/30/2025 03:22
Ono Pharmaceutical’s Tirabrutinib Study: Key Insights for Investors
TipRanks · 10/27/2025 23:02
Ono Pharmaceutical’s Phase 3 Trial: A New Hope for PCNSL Treatment
TipRanks · 10/27/2025 21:42
More
About OPHLF
Ono Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the pharmaceutical business. The Company is engaged in the manufacture and sale of prescription and over-the-counter drugs. The Company has been particularly focused on research and development of prescription drugs, positioning them as its core business. The Company’s products include injectables, oral medications, and patches.

Webull offers Ono Pharmaceutical Co Ltd stock information, including OTCPK: OPHLF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OPHLF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OPHLF stock methods without spending real money on the virtual paper trading platform.